These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32962221)

  • 21. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.
    Drawz SM; Porter S; Kuskowski MA; Johnston B; Clabots C; Kline S; Ferrieri P; Johnson JR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5331-9. PubMed ID: 26100703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extraintestinal pathogenic Escherichia coli sequence type 131 H30-R and H30-Rx subclones in retail chicken meat, Italy.
    Ghodousi A; Bonura C; Di Carlo P; van Leeuwen WB; Mammina C
    Int J Food Microbiol; 2016 Jul; 228():10-3. PubMed ID: 27082892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of Extended-Spectrum β-Lactamase-Producing
    Huang YH; Kuan NL; Yeh KS
    Front Vet Sci; 2020; 7():395. PubMed ID: 32766294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended spectrum β-lactamase and plasmid mediated quinolone resistance in Escherichia coli fecal isolates from healthy companion animals in Algeria.
    Yousfi M; Mairi A; Touati A; Hassissene L; Brasme L; Guillard T; De Champs C
    J Infect Chemother; 2016 Jul; 22(7):431-5. PubMed ID: 27132028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adhesion and invasion to epithelial cells and motility of extended-spectrum β-lactamase-producing Escherichia coli reveal ST131 superiority: a comparative in vitro study of extraintestinal pathogenic E. coli lineages.
    Kondratyeva K; Wollman A; Gerlitz G; Navon-Venezia S
    J Med Microbiol; 2017 Sep; 66(9):1350-1357. PubMed ID: 28825894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ESBL-producing Escherichia coli ST131 versus non-ST131: evolution and risk factors of carriage among French children in the community between 2010 and 2015.
    Birgy A; Levy C; Bidet P; Thollot F; Derkx V; Béchet S; Mariani-Kurkdjian P; Cohen R; Bonacorsi S
    J Antimicrob Chemother; 2016 Oct; 71(10):2949-56. PubMed ID: 27330068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand.
    Rogers BA; Ingram PR; Runnegar N; Pitman MC; Freeman JT; Athan E; Havers S; Sidjabat HE; Gunning E; De Almeida M; Styles K; Paterson DL;
    Int J Antimicrob Agents; 2015 Apr; 45(4):351-8. PubMed ID: 25707371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-H30 Subclone Among Extraintestinal Escherichia coli Collected From US Children.
    Miles-Jay A; Weissman SJ; Adler AL; Tchesnokova V; Sokurenko EV; Baseman JG; Zerr DM
    Clin Infect Dis; 2018 Jan; 66(3):411-419. PubMed ID: 29020219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal carriage of extended-spectrum β-lactamase-producing
    Ouchar Mahamat O; Tidjani A; Lounnas M; Hide M; Benavides J; Somasse C; Ouedraogo AS; Sanou S; Carrière C; Bañuls AL; Jean-Pierre H; Dumont Y; Godreuil S
    Antimicrob Resist Infect Control; 2019; 8():169. PubMed ID: 31695911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
    Kim YA; Lee K; Chung JE
    BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigation of high-risk ST131 clone in ESBL-producing Escherichia coli isolates isolated from urine and non-urinary clinical specimens with MALDI-TOF MS and real time PCR].
    Çizmeci Z; Otlu B; Aktaş E; Ördekçi S; Açıkgöz Ö; Güleç N
    Mikrobiyol Bul; 2018 Jan; 52(1):13-22. PubMed ID: 29642826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.
    Leflon-Guibout V; Blanco J; Amaqdouf K; Mora A; Guize L; Nicolas-Chanoine MH
    J Clin Microbiol; 2008 Dec; 46(12):3900-5. PubMed ID: 18842941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of OXA-48 Carbapenemase and Other β-Lactamase Genes in ESBL-Producing Multidrug Resistant Escherichia coli from Dogs and Cats in the United States, 2009-2013.
    Liu X; Thungrat K; Boothe DM
    Front Microbiol; 2016; 7():1057. PubMed ID: 27462301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal Carriage of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Strains Is Associated with Worse Outcome in Patients Hospitalized in the Pediatric Oncology Unit of Beni-Messous Hospital in Algiers, Algeria.
    Medboua-Benbalagh C; Touati A; Kermas R; Gharout-Sait A; Brasme L; Mezhoud H; Touati D; Guillard T; de Champs C
    Microb Drug Resist; 2017 Sep; 23(6):757-763. PubMed ID: 28095119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carriage of Extended Spectrum Beta Lactamase-Producing
    Werhahn Beining M; Hartmann M; Luebke-Becker A; Guenther S; Schaufler K; Hille K; Kreienbrock L
    Animals (Basel); 2023 Feb; 13(4):. PubMed ID: 36830371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic Resistance of
    Sen K; Berglund T; Soares MA; Taheri B; Ma Y; Khalil L; Fridge M; Lu J; Turner RJ
    Front Microbiol; 2019; 10():1034. PubMed ID: 31156579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.